Arca Biopharma reported $-5675000 in EBITDA for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amgen AMGN:US $ 3004M 337M
Arca Biopharma ABIO:US $ -5.68M 1.58M
Biogen BIIB:US $ 1075.7M 401M
Brainstorm Cell Therapeutics BCLI:US $ -7.52M 2.12M
Bristol Myers Squibb BMY:US $ 5780M 8M
Cytokinetics CYTK:US $ -9.47M 67.05M
Cytrx CYTR:US -1290880 691.86K
Daiichi Sankyo 4568:JP Y 49252M 84953M
Gilead Sciences GILD:US $ 2585M 837M
GlaxoSmithKline GSK:LN 2447M 673M
Laboratory Of America LH:US $ 751.4M 111.8M
Myriad Genetics MYGN:US $ -4.8M 2.9M
Otsuka Holdings 4578:JP Y 69662M 5302M
Pfizer PFE:US $ 12921M 1739M
United Therapeutics UTHR:US $ 214.5M 86M